Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice

International Journal for Parasitology

Volumn 33, Issue 12, 2003, Pages 1373-1383

  Courret, Nathalie ^a,b   Lang, Thierry ^a   Milon, Geneviève ^a   Antoine, Jean Claude ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Cytokines; Leishmania; Lymph nodes; Skin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4;

PARASITISM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; EAR; EXPERIMENTAL INFECTION; EXPERIMENTAL MOUSE; FEMALE; HOST PARASITE INTERACTION; HOST RESISTANCE; IMMUNE RESPONSE; INFECTION RESISTANCE; INOCULATION; LEISHMANIA; LEISHMANIA MAJOR; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PARASITE LOCALIZATION; REINFECTION; SIMULATION; SKIN LEISHMANIASIS; T LYMPHOCYTE; VIRUS TRANSMISSION;

LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR; MAMMALIA;

EID: 0141532988     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(03)00179-6     Document Type: Article

References (55)

1. Afonso L.C., Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun. 61:1993;2952-2959.
2. Antoine J.-C., Jouanne C., Ryter A. Megasomes as the targets of leucine methyl ester in Leishmania amazonensis amastigotes. Parasitology. 99:1989;1-9.
3. Antoine J.-C., Prina E., Lang T., Courret N. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends Microbiol. 6:1998;392-401.
4. Belkaid Y., Bouckson V., Colle J.-H., Goossens P., Lebastard M., Leclercq V., Marchal G., Montixi C., Milon G. Transient inducible events in different tissues: in situ studies in the context of the development and expression of the immune responses to intracellular pathogens. Immunobiology. 191:1994;413-423.
5. Belkaid Y., Mendez S., Lira R., Kadambi N., Milon G., Sacks D.L. A natural model of Leishmania major infection reveals a prolonged 'silent' phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol. 165:2000;969-977.
6. Belkaid Y., Hoffmann K.F., Mendez S., Kamhawi S., Udey M.C., Wynn T.A., Sacks D.L. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med. 194:2001;1497-1506.
7. Belosevic M., Davis C.E., Meltzer M.S., Nacy C.A. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-γ for induction of resistance to infection. J Immunol. 141:1988;890-896.
8. Berens R.L., Marr J.J. An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J Parasitol. 64:1978;160.
9. Bhattacharya A., Dorf M.E., Springer T.A. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J Immunol. 127:1981;2488-2495.
10. Biegel D., Topper G., Rabinovitch M. Leishmania mexicana: temperature sensitivity of isolated amastigotes and of amastigotes infecting macrophages in culture. Exp Parasitol. 56:1983;289-297.
11. Blank C., Fuchs H., Rappersberger K., Röllinghoff M., Moll H. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J Infect Dis. 167:1993;418-425.
12. Bretscher P.A., Wei G., Menon J.N., Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science. 257:1992;539-542.
13. Courret N., Prina E., Mougneau E., Saraiva E.M., Sacks D.L., Glaichenhaus N., Antoine J.-C. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur J Immunol. 29:1999;762-773.
14. Courret N., Fréhel C., Prina E., Lang T., Antoine J.-C. Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages. Parasitology. 122:2001;263-279.
15. da Costa A.V., Huerre M., Delacre M., Auriault C., Correia Costa J.M., Verwaede C. IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. Parasitol Int. 51:2002;367-379.
16. Doherty T.M., Coffman R.L. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp Parasitol. 84:1996;124-135.
17. Gaafar A., Ismail A., El Kadaro A.Y., Hashim E., Khalil E.A.G., El Hassan A.M. Necrotizing and suppurative lymphadenitis in Leishmania major infections. Trop Med Int Health. 1:1996;243-250.
18. Groux H., Cottrez F., Rouleau M., Mauze S., Antonenko S., Hurst S., McNeil T., Bigler M., Roncarolo M.G., Coffman R.L. A transgenic model to analyse the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol. 162:1999;1723-1729.
19. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med. 169:1989;59-72.
20. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA. 88:1991;7011-7015.
21. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med. 177:1993;1505-1509.
22. Jones D.E., Buxbaum L.U., Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol. 165:2000;364-372.
23. Jones D.E., Ackermann M.R., Wille U., Hunter C.A., Scott P. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun. 70:2002;2151-2158.
24. Kamhawi S., Belkaid Y., Modi G., Rowton E., Sacks D.L. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science. 290:2000;1351-1354.
25. Kane M.M., Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol. 166:2001;1141-1147.
26. Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol. 18:1988;97-104.
27. Lainson R., Shaw J.J. Leishmaniasis in Brazil: I. Observations on enzootic rodent leishmaniasis-incrimination of Lutzomyia flaviscutellata (Mangabeira) as the vector in the lower amazonian basin. Trans R Soc Trop Med Hyg. 62:1968;385-395.
28. Lainson R., Shaw J.J. Leishmaniasis in Brazil: V. Studies on the epidemiology of cutaneous leishmaniasis in Mato Grosso state, and observations on two distinct strains of Leishmania isolated from man and forest animals. Trans R Soc Trop Med Hyg. 64:1970;654-667.
29. Lang T., Courret N., Colle J.-H., Milon G., Antoine J.-C. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum. Infect Immun. 71:2003;2674-2683.
30. Leclercq V., Lebastard M., Belkaid Y., Louis J., Milon G. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol. 157:1996;4537-4545.
31. + cells in experimental leishmaniasis. Infect Immun. 56:1988;2120-2124.
32. Matthews D.J., Emson C.L., McKenzie G.J., Jolin H.E., Blackwell J.M., McKenzie A.N. IL-13 is a susceptibility factor for Leishmania major infection. J Immunol. 164:2000;1458-1462.
33. Menon J.N., Bretscher P.A. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Eur J Immunol. 26:1996;243-249.
34. Menon J.N., Bretscher P.A. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur J Immunol. 28:1998;4020-4028.
35. Moore K.J., Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol. 152:1994;2930-2937.
36. Mortatti R.C., Henriques A. Experimental cutaneous leishmaniasis by Leishmania amazonensis: course of fast-growth infection in the mouse ear. Parasitol Res. 76:1990;729-730.
37. Nakajima-Shimada J., Zou C., Takagi M., Umeda M., Nara T., Aoki T. Inhibition of Fas-mediated apoptosis by Trypanosoma cruzi infection. Biochim Biophys Acta. 1475:2000;175-183.
38. Nash P.B., Purner M.B., Leon R.P., Clarke P., Duke R.C., Curiel T.J. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol. 160:1998;1824-1830.
39. Noben-Trauth N., Paul W.E., Sacks D.L. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162:1999;6132-6140.
40. + T cells in vivo. J Immunol. 167:2001;4534-4542.
41. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu Rev Immunol. 13:1995;151-177.
42. Rioux J.-A., Lanotte G., Petter F., Dereure J., Akalay O., Pratlong F., Velez I.D., Fikri N.B., Maazoun R., Denial M., Jarry D.-M., Zahaf A., Ashford R.W., Cadi-Soussi M., Killick-Kendrick R., Benmansour N., Moreno G., Périères J., Guilvard E., Zribi M., Kennou M.-F., Rispail P., Knechtli R., Serres E. Les leishmanioses cutanées du bassin méditerrannéen occidental. Rioux J.-A., Serres E. Leishmania. Taxonomie et phylogenèse. Applications éco-épidé miologiques. 1986;365-395 IMEEE, Montpellier.
43. Sacks D.L. Metacyclogenesis in Leishmania promastigotes. Exp Parasitol. 69:1989;100-103.
44. Sacks D.L., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2:2002;845-858.
45. Sacks D.L., Barral A., Neva F.A. Thermosensitivity patterns of old versus new world cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. Am J Trop Med Hyg. 32:1983;300-304.
46. Sacks D.L., Hieny S., Sher A. Identification of cell surface carbohydrate and antigenic changes between non-infective and infective developmental stages of Leishmania major promastigotes. J Immunol. 135:1985;564-569.
47. Soong L., Xu J.C., Grewal I.S., Kima P., Sun J., Longley B.J. Jr, Ruddle N.H., McMahon-Pratt D., Flavell R.A. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 4:1996;263-273.
48. + T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol. 158:1997;5374-5383.
49. Stenger S., Thüring H., Röllinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med. 180:1994;783-793.
50. Strijbosch L.W., Buurman W.A., Does R.J., Zinken P.H., Groenewegen G. Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods. 97:1987;133-140.
51. Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., Schaub R.G. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med. 177:1993;1797-1802.
52. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 126:1981;1614-1619.
53. Uzonna J.E., Wei G., Yurkowski D., Bretscher P. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J Immunol. 167:2001;6967-6974.
54. Warburg A., Schlein Y. The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. Am J Trop Med Hyg. 35:1986;926-930.
55. Weintraub J., Gottlieb M., Weinbaum F.I. Leishmania tropica: association of a B-cell mitogen with hypergammaglobulinemia in mice. Exp Parasitol. 53:1982;87-96.